The dysfunction of mDia1, insufficiency of sGC activity and ARHGEF3 downregulation by miR-512-3p in MMD converge mechanistically, all shifting the balance away from RHOA activation via distinct molecular levers. This evidence concerns the gene DIAPH1 and multiminicore myopathy.